Medicare Procedure and Patient Information
2019 Medicare Patient Data
Information about Medicare patients treated by Dr. Christopher Robert Dangelo, MD.
| Non-Hispanic White | |
|---|---|
| Black | |
| Hispanic | |
| Asian | |
| Other | |
| Native American |
Dr. Christopher Robert Dangelo, MD is a medical oncologist in Omaha, NE specializing in medical oncology, adult oncology and adult hematology. He graduated from University of Illinois College of Medicine in 2013 and has 12 years of experience. Dr. Christopher Robert Dangelo, MD is affiliated with Nebraska Medicine and UNMC PHYSICIANS.
Click on any procedure below to see further details on volume and pricing among Medicare patients.
In 2023, Dr. Christopher Robert Dangelo, MD performed more inpatient hospital care (for patient admitted to hospital) procedures for Medicare patients than 90% of providers in related specialties within Nebraska.
Information about Medicare patients treated by Dr. Christopher Robert Dangelo, MD.
| Non-Hispanic White | 11 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
The top procedures that Dr. Christopher Robert Dangelo, MD treated as a medical oncologist in Omaha, NE during 2020 were hospital care and inpatient care.
Volume of procedures performed by Dr. Christopher Robert Dangelo, MD for Medicare patients.
| doctor visit | 62 |
|---|---|
| hospital care | 125 |
| inpatient care | 125 |
Information about Medicare patients treated by Dr. Christopher Robert Dangelo, MD.
| Male | 50 |
|---|---|
| Female | 46 |
| From 65 to 74 | 60 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 0 |
The most common conditions of Medicare patients that Dr. Christopher Robert Dangelo, MD treated during 2020 were hypertension, chronic kidney disease, high cholesterol and ischemic heart disease.
| Hypertension | 69 |
|---|---|
| High Cholesterol | 56 |
| Stroke | 0 |
| Ischemic Heart Disease | 38 |
| Depression | 36 |
| Chronic Kidney Disease | 58 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 19 |
| Heart Failure | 25 |
| Chronic Obstructive Pulmonary Disease | 13 |
| Diabetes | 25 |
| Dementia | 11 |
| Cancer | 11 |
The top procedures that Dr. Christopher Robert Dangelo, MD treated as a medical oncologist in Omaha, NE during 2021 were hospital care and inpatient care.
Volume of procedures performed by Dr. Christopher Robert Dangelo, MD for Medicare patients.
| doctor visit | 320 |
|---|---|
| hospital care | 267 |
| inpatient care | 267 |
Information about Medicare patients treated by Dr. Christopher Robert Dangelo, MD.
| Male | 94 |
|---|---|
| Female | 90 |
| Non-Hispanic White | 159 |
|---|---|
| Black | 12 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 105 |
|---|---|
| From 75 to 84 | 49 |
| 85 and over | 0 |
| Less than 65 | 0 |
The most common conditions of Medicare patients that Dr. Christopher Robert Dangelo, MD treated during 2021 were hypertension, high cholesterol, chronic kidney disease and ischemic heart disease.
| Hypertension | 73 |
|---|---|
| High Cholesterol | 58 |
| Stroke | 7 |
| Ischemic Heart Disease | 42 |
| Depression | 36 |
| Chronic Kidney Disease | 50 |
| Asthma | 0 |
| Osteoperosis | 7 |
| Atrial Fibrilation | 19 |
| Heart Failure | 24 |
| Chronic Obstructive Pulmonary Disease | 15 |
| Diabetes | 29 |
| Dementia | 13 |
| Cancer | 9 |
The top procedures that Dr. Christopher Robert Dangelo, MD treated as a medical oncologist in Omaha, NE during 2022 were hospital care and inpatient care.
Volume of procedures performed by Dr. Christopher Robert Dangelo, MD for Medicare patients.
| doctor visit | 339 |
|---|---|
| hospital care | 253 |
| inpatient care | 253 |
Information about Medicare patients treated by Dr. Christopher Robert Dangelo, MD.
| Male | 99 |
|---|---|
| Female | 97 |
| Non-Hispanic White | 176 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 110 |
|---|---|
| From 75 to 84 | 54 |
| 85 and over | 0 |
| Less than 65 | 0 |
The most common conditions of Medicare patients that Dr. Christopher Robert Dangelo, MD treated during 2022 were hypertension, high cholesterol, chronic kidney disease and atrial fibrilation.
| Hypertension | 75 |
|---|---|
| High Cholesterol | 64 |
| Stroke | 12 |
| Ischemic Heart Disease | 31 |
| Depression | 29 |
| Chronic Kidney Disease | 33 |
| Asthma | 7 |
| Osteoperosis | 14 |
| Atrial Fibrilation | 32 |
| Heart Failure | 26 |
| Chronic Obstructive Pulmonary Disease | 17 |
| Diabetes | 32 |
| Dementia | 0 |
| Cancer | 14 |
The top procedures that Dr. Christopher Robert Dangelo, MD treated as a medical oncologist in Omaha, NE during 2023 were hospital care and inpatient care.
Volume of procedures performed by Dr. Christopher Robert Dangelo, MD for Medicare patients.
| doctor visit | 408 |
|---|---|
| hospital care | 372 |
| inpatient care | 372 |
Information about Medicare patients treated by Dr. Christopher Robert Dangelo, MD.
| Male | 130 |
|---|---|
| Female | 104 |
| Non-Hispanic White | 216 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 136 |
|---|---|
| From 75 to 84 | 65 |
| 85 and over | 15 |
| Less than 65 | 18 |
The most common conditions of Medicare patients that Dr. Christopher Robert Dangelo, MD treated during 2023 were hypertension, high cholesterol, chronic kidney disease and diabetes.
| Hypertension | 74 |
|---|---|
| High Cholesterol | 68 |
| Stroke | 12 |
| Ischemic Heart Disease | 32 |
| Depression | 24 |
| Chronic Kidney Disease | 34 |
| Asthma | 9 |
| Osteoperosis | 13 |
| Atrial Fibrilation | 28 |
| Heart Failure | 24 |
| Chronic Obstructive Pulmonary Disease | 20 |
| Diabetes | 32 |
| Dementia | 8 |
| Cancer | 17 |
Volume of procedures performed by Dr. Christopher Robert Dangelo, MD for Medicare patients.
The highest averages for the top procedures that Dr. Christopher Robert Dangelo, MD treated as a medical oncologist in Omaha, NE were hospital care and inpatient care.
| doctor visit | 282 |
|---|---|
| hospital care | 254 |
| inpatient care | 254 |
Information about Medicare patients treated by Dr. Christopher Robert Dangelo, MD.
| Male | 74 |
|---|---|
| Female | 67 |
| Black / African American | 2 |
|---|---|
| Asian / Pacific Islander | 0 |
| Non-Hispanic White | 112 |
| Hispanic | 0 |
| Native American / Alaskan Native | 0 |
| Other | 0 |
| 75 to 84 | 33 |
|---|---|
| 85 and over | 3 |
| Less than 65 | 3 |
| 65 to 74 | 82 |
The highest averages of the most common conditions of Medicare patients that Dr. Christopher Robert Dangelo, MD treated were hypertension, high cholesterol, chronic kidney disease and ischemic heart disease.
| Hypertension | 58 |
|---|---|
| High Cholesterol | 49 |
| Stroke | 6 |
| Ischemic Heart Disease | 28 |
| Depression | 25 |
| Chronic Kidney Disease | 35 |
| Asthma | 3 |
| Osteoporosis | 6 |
| Heart Failure | 19 |
| Chronic Obstructive Pulmonary Disease | 13 |
| Diabetes | 23 |
| Atrial Fibrillation | 19 |
| Dementia | 6 |
| Cancer | 10 |
Dr. Christopher Robert Dangelo, MD graduated from University of Illinois College of Medicine in 2013. He completed residency at University of Chicago Medical Center. He is certified by the Board Certification: Hematology and has a state license in Nebraska.
Medical School: University of Illinois College of Medicine (2013)
Residency: University of Chicago Medical Center (2016)
Board Certification: Board Certification: Hematology
Licensed In: Nebraska
Dr. Christopher Robert Dangelo, MD is associated with these hospitals and organizations:
Dr. Christopher Robert Dangelo, MD has an exceptional overall rating with an average of 5.0 out of 5 stars based on 224 ratings. We collect ratings and reviews of Dr. Christopher Robert Dangelo, MD from all over the web to help you find the right in Omaha, NE.
These charts describe general payments received by Dr. Christopher Robert Dangelo, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Seagen Inc. |
$9,594
ADCETRIS $9,594 |
|---|---|
| Genmab U.S., Inc. |
$4,484
Epkinly $4,484 |
| E.R. Squibb & Sons, L.L.C. |
$4,168
$4,168 |
| AbbVie Inc. |
$2,877
Venclexta $2,877 |
| BeiGene USA, Inc. |
$2,291
BRUKINSA $2,291 |
| Other |
$1,522
$1,522 |
| Consulting Fee | $20,131 |
|---|---|
| Travel and Lodging | $2,658 |
| Food and Beverage | $1,694 |
| Compensation for serving as faculty or as a speaker for a medical education program | $454 |
Dr. Christopher Robert Dangelo, MD has received 127 research payments totaling $1,791,433.
Dr. Christopher D'angelo is a specialist in adult hematology, adult oncology, and medical oncology in Omaha, NE and Bellevue, NE. After attending the University of Illinois College of Medicine for medical school, Dr. D'angelo completed his residency training at the University of Chicago Medical Center. His clinical interests include leukemia, hodgkin's lymphoma, and chemotherapy. His average rating from his patients is 5.0 stars (out of 5). He is affiliated with Nebraska Medicine.